Marker For Antidepressant Therapy And Methods Related Thereto

Abstract

The present invention relates generally to methods for determining the effectiveness of ongoing antidepressant therapy via analysis of the association of G<SUB>salpha</SUB> with components of the plasma membrane or cytoskeleton of cells from peripheral tissues of the depressed individual as well as to methods involved in screening for effective antidepressant agents via their ability to cause a difference in the association of G<SUB>salpha</SUB> with components of the plasma membrane or cytoskeleton of cells.


Claims
Download PDF
Document Preview
Document History
  • Publication: Oct 10, 2006
  • Application: Feb 8, 2005
    US US 5351605 A
  • Priority: Feb 8, 2005
    US US 5351605 A
  • Priority: Jul 30, 2001
    US US 91823001 A
  • Priority: Jul 29, 2000
    US US 22187400 P

Sign in to the Lens

Feedback